Product Information
CEFTRIAXONE 250 MG VIAL is a generic product labeled by Sandoz Inc., priced at $0.8622 per EA under NDC 00781320695. Its NADAC has been published 318 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Sandoz Inc.NDC
00781320695
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
2/18/2026
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065169On Market Since
5/9/2005
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 250 MG VIAL has been published 318 times since Nov 28, 2013, and over the history we have for it it has declined 37.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8622 per EA |
|---|---|
| All-time high | $1.3996 (Nov 12, 2014) |
| All-time low | $0.7788 (Dec 21, 2016) |
| 52-week high | $0.8622 |
| 52-week low | $0.8410 |
| Median price | $0.9926 |
| Average price | $1.0095 |
| Largest weekly change | +30.9% (Jan 20, 2016) |
| Weeks tracked | 318 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 250 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 250 MG VIAL, manufactured by Sandoz Inc., is $0.8622 per EA (NDC 00781320695), effective Jun 24, 2026.
How has the price of CEFTRIAXONE 250 MG VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 250 MG VIAL has declined 37.3%. It has been tracked across 318 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 250 MG VIAL?
Since Nov 28, 2013, the NADAC for CEFTRIAXONE 250 MG VIAL has ranged from a low of $0.7788 (Dec 21, 2016) to a high of $1.3996 (Nov 12, 2014), with a median of $0.9926 per EA.
Are there cheaper alternatives to CEFTRIAXONE 250 MG VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CEFTRIAXONE 250 MG VIAL, but none are currently priced below it.
Who manufactures CEFTRIAXONE 250 MG VIAL?
CEFTRIAXONE 250 MG VIAL (NDC 00781320695) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification